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Abstract
Cytotoxic T lymphocytes (CTLs) play an important role in shaping HIV-1 infection. In particular, during the first weeks
of infection, CTLs select for multiple escape mutations in the infecting HIV population. In recent years, methods have
been developed that use intra-patient escape mutation data to estimate rates of escape from CTL selection. The resultant
escape rate estimates have been used to study CTL kill rates and fitness costs associated with particular mutations, thereby
providing a quantitative framework for exploring CTL response and HIV dynamics using patient datasets. Current methods
for escape rate inference focus on a specific HIV mutant selected by a single CTL response. However, recent studies have
shown that during the first weeks of infection, CTL responses occur at 1 − 3 epitopes and HIV escape occurs through
complex mutation pathways. In this work we develop a model of initial infection, based on the well-known standard model,
that allows us to model the complex mutation pathways of HIV escape. Under this model, we develop two computational
inference methods. In one, we use a Bayesian approach to construct posteriors for the parameters of our model. In the
second, we develop methods for hypothesis testing under our model. The methods are applied to two CHAVI datasets,
demonstrating the importance of taking into account the interaction of multiple mutant variants and multi-directional
selection.
1 Introduction
Acute HIV-1 infection is marked by a period of approximately 2 − 4 weeks in which the viral population expands from a
presumed 1 − 5 initial infected cells, in the case of sexual transmission [1], to a population of approximately 109 infected
cells [2–5]. An innate immune response occurs within about 5 days of initial infection, but the adaptive response takes
more time. In particular, cellular response is correlated temporally with the end of the expansion period. [5–7].
Adaptive response during the acute phase of infection includes both a T cell and antibody component, but neutralizing
antibodies only arise towards the end of the acute phase or later in infection [8, 9]. In contrast, there is strong evidence
suggesting that CTLs do exert a significant selective force around the time of peak viral load [10, 11]. For example, in the
four patients considered in [11], initial CTL response targeting a single epitope started at or several days before peak viral
load and escape mutations at the epitope were fixed or nearly so 2 − 3 weeks thereafter. Shortly after the initial CTL
response, CTL responses at 1 − 2 other epitopes was seen. Escape mutations at these epitopes were fixed or nearly so
within roughly 4− 6 weeks of peak viral load.
While the description above provides a qualitative picture of initial CTL response and HIV escape, an accompanying
quantitative description is still being developed. Put in evolutionary terms, HIV escape from CTL response forms an
example of a selective sweep. A quantitative theory of selective sweeps does exist, e.g. [12–16], but this theory typically
builds off generic models that do not fit the biology of acute HIV infection in several ways. First, the HIV population size
is not fixed during initial infection, instead HIV viral load rises by 2− 4 logs, peaks, and then drops by 2− 3 logs during
the time span of the initial HIV selective sweep [2, 11, 17]. Second, since CTL populations change over the time period of
the sweep, the selective force exerted by CTLs is time varying. Third, since CTLs target multiple epitopes and the fitness
effects of mutations are complex, the selective force exerted on the HIV population is multi-directional. Fourth, the high
mutation rate of HIV means not only that many mutant variants will arise, but also that multiple mutation pathways
leading to escape will exist. As a result, providing a quantitative description of HIV selective sweeps during initial infection
is a modeling and computational challenge.
Several authors have examined selection in the context of HIV, e.g. [15,18–21], but not with a focus on making inferences
on selective sweeps in acute infection and, consequently, not with models that reflect the unique features of CTL response
and HIV dynamics during acute infection. Techniques have been developed to infer HIV escape rates by focusing on mutant
frequency at a single epitope [10,11,22–24]. These techniques have been valuable in quantifying the role of CTL attack in
shaping HIV escape rates. However, the model used considers a single genome region and assumes only two HIV variants
at that region, a wild type variant and a mutant variant. As a result, the effect of different HIV variants exposed to
multi-directional selection is difficult to assess.
∗Department of Mathematics and Statistics, Georgetown University, Washington, DC, USA. E-mail: sr286@georgetown.edu
1
ar
X
iv
:1
20
8.
29
81
v1
  [
q-
bio
.PE
]  
14
 A
ug
 20
12
In this work, we describe a model and associated computational methods through which HIV selective sweeps driven by
multi-epitope CTL response and multi-variant HIV escape can be analysed. The model is based on the standard model of
viral dynamics [25]. Since HIV mutants that escape CTL attack do not exist at initial infection and often arise sequentially
in time, we extend the deterministic standard model to a stochastic birth-death process that includes mutation. Intuitively,
the birth-death process is an agent-based system that tracks the birth, death, and mutation events of individual cells
infected by different HIV variants. Such an approach to HIV dynamics has been used previously, e.g. [26–28]. We model
the possible mutation pathways by what we term an escape graph. The escape graph, formed through information available
in the datasets considered, specifies the different mutations and resultant HIV variants that are involved in the selective
sweep and tracked by the birth-death process.
Given a model, specified through an escape graph and associated birth-death process, we develop two computational
inference methods. First, assuming a prior distribution on the parameters of the birth-death process, we describe a
computational approach to forming a posterior parameter distribution. Posteriors describe the most likely parameters
conditioned on the data, but they do not directly describe the overall fit of the model to the data. So second, we describe
a computational approach that determines the p-value of a specific escape graph and associated birth-death process. This
allows for hypothesis testing.
We apply our computational methods to the datasets of patients CH40 and CH58 presented in [11, 29], focusing our
analysis on the first 2 − 3 timepoints sampled in [11]. Our methods use data that specifies frequencies of different HIV
variants at different sampled time points, the type of data available in [11,29]. For CH58, we focus our analysis on the first
two regions of the founder genome at which mutations are seen to fix. One region is the epitope targeted by the initial CTL
response and the other region is possibly associated with fitness effects. Mutations fix at these two regions simultaneously
and we construct posteriors to analyze how these simultaneous sweeps affect each other. For CH40, we consider escape
from the initial CTL response. Through deep sequencing data for CH40 presented in [29], 7 different mutations at the
epitope targeted are seen to play a part in escape. By exploiting our p-value computations to perform hypothesis tests,
we show that variations in mutant frequency seen in the CH58 dataset are not necessarily reflective of difference in CTL
kill rates or fitness difference, but rather may result from the stochasticity inherent in the time at which different mutant
variants arise.
Calculating posteriors and p-values under our model is not computationally trivial. The model is stochastic and the
data is high-dimensional. Standard Monte Carlo approaches in which the birth-death process is simulated without any
conditioning are not effective because the data represents a single point in a high dimensional space and the birth-death
process rarely hits any specific point. Further, since the data is high-dimensional, defining what is meant by a p-value
is not straightforward. We address these issue by exploiting a stochastic-deterministic decomposition of HIV birth-death
processes introduced and explored by several authors [30–33]. Using this decomposition, we construct a reduction that
associates the birth-death process with a stochastically simpler Markov chain. Through this Markov chain reduction, the
posterior can be computed using a Markov Chain-Monte Carlo approach and the p-value can be defined and computed.
2 Model and Methods
Our model is based on the following form of the standard model for which virions are assumed to be in steady state, [25,34]
T˙ (t) = λ− dT − kT
∑
v
Iv (1)
I˙v(t) = kTIv − δvIv
where T, Iv represent uninfected target CD4+ T cells and CD4+ T cells infected by HIV variant v, respectively, per µL.
To allow for multiple variants, v varies over whatever set of variants is being considered. k, λ, d represent the infection rate
per target cell per µL, target cell production rate per µL, and target cell death rate, respectively, per day. Crucial for our
model, δv represent the death rates of cells infected by variant v. Instead of explicitly modeling CTL dynamics, we allow
the parameters δv for different variants to vary in time and in this way model the selective force exerted by CTLs or other
fitness effects implicitly.
To model the mutation pathways through which HIV variants escape selection, we define an escape graph by specifying
a set of vertices and a set of directed edges. Vertices correspond to HIV variants that are part of the mutation pathway
through which the selective sweep occurs. Two vertices, say A and B, may be connected by an edge directed from A to
B if variant A can mutate into variant B through a single nucleotide substitution. We write A → B when A has an edge
pointing to B. Figure 1 shows an escape graph with three variants : F , M1, and M12. In the results section, this escape
graph arises in connection to patient CH58. F represents the original founder HIV variant that infected the patient. The
movement from variant F to M1 to M12 represents a pathway of HIV escape suggested by the patient data. The specific
geometry of this graph, which ignores certain variants, reflects a modeling choice. Figure 2 shows the escape graph we use
for patient CH40.
A birth-death process describes the dynamics of the variant populations specified by the escape graph vertices and is
an extension of (1). T (t) and Iv(t) represent the same populations as in the standard model, with the caveats that the
2
Figure 1. Escape Graph for CH58
Figure 2. Escape Graph for CH40
v’s are vertices in the escape graph and the units are now per body rather than per µL. The change in units allows us to
track the rise of new variants which initially only infect a single cell. The parameters of the birth-death process include
the parameters of (1) with two extensions. First, we allow δv to depend on time, i.e. we consider δv(t) instead of just
δv. Second, if A and B are connected by an edge we let µAB be the rate at which A variants mutate into B variants.
Throughout this work we set all such mutation rates equal to µ = 3 ∗ 10−5, but the methods allow for any value for any
edge. The birth-death process is defined through the birth and death rates specified in Table 1. For example, at time
t a single cell infected by variant v produces child infected cells with rate kT (t), meaning that in a small time interval
[t, t + ∆t] the probability of a new v variant infected cell arising is roughly kT (t)Iv(t)∆t. In both cases discussed in the
Results section, the escape graph includes a founder vertex F . We always start the birth-death process at ’initial infection’
which we model as t = 0, IF (0) = 1 and Iv(0) = 0 for v 6= F .
Table 1. Rates for the Birth-Death Process
cell type birth rate death rate mutation rate
T λ d+
∑
v kIv -
Iv kT δv(t) µ
∑
v′→v kTIv′
Since we do not explicitly model CTL dynamics, the δv(t) which implicitly model CTL attack are parameters of special
interest. In computing posteriors, estimating δv(t) with no restrictions is beyond our current methods. Instead, along with
the escape graph and birth-death rates we specify a list of attack intervals [0, t1], [t1, t2], . . . , [tn−1, tn] and restrict the δv(t)
to be constant during any attack interval. For example, we often choose t1 = 15 reflecting approximately 15 days before
CTL response arises and correspondingly choose δv(t) = .4 for t ∈ [0, 15] which gives a half-life for infected cells falling
between 1− 2 days [17,35]. Posterior construction centers on computing the values of the δv(t) during the attack intervals.
In the Results section, k, d, λ, µ are fixed within each patient, although these parameters can certainly be made part of the
prior and posterior. The specific form of the attack intervals is a modeling choice and is formed by considering CTL data
available. Start and end times for the attack intervals can be made part of the posterior as is done for patient CH40.
2.1 Simulation of the Birth-Death Process
Simulating a birth-death process through a Gillespie algorithm, [36], is not computationally feasible for an infected cell
population size of the order 109. Instead we employ the idea of stochastic-deterministic decomposition used by several
authors [30–33]. To make this decomposition precise, for each variant v we define a stochastic interval, [t
(v)
start, t
(v)
end]. Given
the stochastic interval, Iv(t) dynamics are generated according to the following algorithm,
Pre-Stochastic Interval Step:
For t < t
(v)
start, Iv(t) = 0.
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Stochastic Interval Step:
For t ∈ [t(v)start, t(v)end], Iv(t) dynamics are generated by a Gillespie algorithm using the rates of the birth-death process.
Post-Stochastic Interval Step:
For t > t
(v)
end, Iv(t) dynamics are approximated using the differential equation:
I˙v = kTIv − δv(t)Iv + µ
∑
v′→v
kTIv′ . (2)
The above algorithm can be employed for each variant, but in practice we assume that the founder variant is deterministic
from t = 0. This approach ignores stochasticity in the first 1 − 2 days of infection, a time period that does not affect our
results and for which the modeling is uncertain with the advantage of improved computational time. For all other variants,
since the Gillespie algorithm samples exactly from the birth-death process, the accuracy of the stochastic-deterministic
decomposition improves as the stochastic interval is widened, but at the cost of greater computation time. The endpoints
of the stochastic intervals are set through tuning parameters  and L. These two parameters tune the algorithm by implicitly
selecting a trade-off between computational speed and accuracy.
To explain how we determine the stochastic interval, we consider the escape graph in Figure 1. Starting with variant
M1, since F does not have a stochastic interval, t
(M1)
start is defined by µkT (t
(M1)
start )IF (t
(M1)
start ) = , i.e. the time at which the
rate of mutations reaches . The probability of an F to M1 mutation prior to t
(M1)
start is order . The error of ignoring such
mutations, as is done by the Pre-Stochastic Interval Step, drops as  is decreased. t
(M1)
end is defined by I˜M1(t
(M1)
end ) = L
where I˜M1(t) is roughly the average population size of M1 variants. Put precisely, let t
∗ be defined by µkIF (t∗)T (t∗) = 1,
then I˜M1(t) obeys (2) with initial condition I˜(t
∗) = 0. As L is increased, t(M1)end rises thereby increasing the duration of the
stochastic interval and improving accuracy. The stochastic interval of M12 is generated similarly, but with M1 playing
the role of F . For a general escape graph, we would start with the founder and work our way outwards along the edges,
generating a stochastic interval for each vertex.
In [33], through simulation the relative error produced by L = 100,  = 0 was found to be approximately .03. Similar
results, expressed in somewhat different settings, were found in [30, 32]. Figure 3A shows the probability density of
IM1(15), the number of M1 variant infected cells at t = 15, computed using the stochastic-deterministic decomposition
with L = 2000,  = 0. Parameters were set at k = 2 ∗ 10−3, d = .01, λ = 108, and δv = .4 for v = F,M1,M12. These
parameter choices fall within the typical range used for HIV, e.g. [17,37–39], with the caveat that λ, k must be converted to
per body units and remembering that we assume virions are in steady state. (For example, the k = 2 ∗ 10−3 in our model
corresponds to k = 1.2 ∗ 10−5 in the model of [39], approximately the value cited in that paper.) The stochastic interval for
M1 was [4.6, 13.7], so by t = 15 the M1 variants were in the deterministic portion of the decomposition. Figure 3B shows
the difference in the cumulative distribution between using L = 2000 and an exact Gillespie distribution run up to t = 15.
As can be seen the maximum difference in the cdfs is less than .01. In the Results section, we make the conservative choice
of L = 2000, although L = 100 is likely sufficient. To simulate the birth-death process, choosing  = 0 is computationally
feasible, however the Markov chain reduction depends on  > 0 as will be discussed below.
Number of M1 variants at t=15
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Figure 3. Accuracy of Stochastic-Determinsitic Decomposition. (A) Distribution of IM1(15), the number of M1
variants at t = 15, with parameters k = 2.6 ∗ 10−3, d = .01, λ = 108 and δv = .4 for v = F,M1,M12. (B) Difference of
cumulative distributions for IM1(15) using Gillespie simulation and stochastic-deterministic decomposition with L = 2000.
Both (A) and (B) were generated using 106 simulations.
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2.2 Markov Chain Reduction of the Birth-Death Process
While simulation of the birth-death process is possible using the algorithm of the previous section, inference is difficult.
To overcome this obstacle, we reduce the stochasticity of the birth-death process to the much simpler stochasticity of a
Markov chain. The computational approaches used to construct posteriors and p-values depend on this reduction.
As a first step in obtaining the Markov chain reduction, we modify the simulation algorithm described in the previous
section. Everything is as before, except that the Stochastic Interval Step is now implemented through the following sub-steps
which do not use a Gillespie simulation.
Modified Stochastic Interval Step, sub-step a
Set Iv(t) = 0 for all t ∈ [t(v)start, t(v)end). During this time interval, store T (t) and Iv′(t) for all v′ with an edge pointing
to v.
Modified Stochastic Interval Step, sub-step b
Let B(t) be a single variant birth-death process, i.e. B(t) is a scalar, defined by B(t
(v)
start) = 0 and with birth, death, and
mutation rates of kT (t), δv(t), and
∑
v′→v µkT (t)Iv′(t), respectively. B(t) has the same birth, death, and mutation
rates as variant v infected cells. Define Xv = B(t
(v)
end). Since T (t), Iv′(t) were stored in sub-step a, the distribution of
Xv can be computed through standard methods, see [39] for an example in the context of viral dynamics. Briefly, Xv
is computed by solving a backwards equation for the expected value E[exp[−iωB(t(v)end)] | B(t) = 1]. Then a Fourier
transform in ω is performed to obtain the distribution of B(t
(v)
end) or in other words Xv.
Modified Stochastic Interval Step, sub-step c
Using the distribution computed in sub-step b, produce a sample xˆv from Xv. Set Iv(t
(v)
end) = xˆv.
The above algorithm samples the number of variants at the end of the stochastic interval exactly, under the assumption that
v variant dynamics during the stochastic interval do not effect T (t) dynamics, i.e. the number of CD4+ target cells. Since
a variant v will have population size of order L, for L less than 10000 the v variant population will have a frequency on the
order of 10−5. Such low frequencies cannot be sampled by even deep sequencing approaches so ignoring the dynamics does
not limit connection to data. Further, the error produced by ignoring such a low frequency variant in computing birth-death
process dynamics is dominated by the error produced by the stochastic-deterministic decomposition, the sampling error
associated with the data, the error produced by solving equations such as (2) numerically, and the stochasticity of the birth-
death process. For example, in the context of Figure 3 discussed in the previous section, the difference between T (15) and
IF (15) under the Modified Stochastic Interval Step as opposed to the Stochastic Interval Step is approximately 10
−7. Such
a difference is clearly dominated by the stochasticity of the birth death process and the error of the stochastic-deterministic
decomposition as shown in Figures 3A-B.
Using this new simulation approximation, the stochasticity of the birth-death process is reduced to the variables Iv(t
(v)
end)
or in other words the draws of the samples xˆv from the distributions Xv. To see this notice that except for sampling from
xˆv for all variants v 6= F , the simulation of the birth-death process is completely deterministic. We refer to Xv and xˆv
as the pop size distribution and pop size of the v variant population because, intuitively, xˆv determines how soon the v
variant population has significant frequency and hence ’pops up’ in the data.
For appropriate choices of  and L the stochasticity of the birth-death process can be further simplified. For concreteness,
consider the escape graph of Figure 1. If  is chosen large enough and L is chosen small enough then t
(M1)
end < t
(M12)
start , i.e.
the stochastic interval of M1 will end before the stochastic interval of M12 starts. In this case, the stochastic interval of
M1 will be considered first, the distribution of XM1 generated, and xˆM1 sampled. Only once xˆM1 has been sampled will
the dynamics be run forward to the M12 stochastic interval. Then, XM12 will be generated and xˆM12 will be sampled.
Putting all this together, xˆM1 and xˆM12 are states in a Markov chain. Further, the dynamics of the birth-death process
are deterministic other than the choices of xˆM1 and xˆM12. In this sense, the birth-death process is reduced to a Markov
chain. For more complex escape graphs, the idea is the same with the linear Markov chain of the example being replaced
by a Markov chain on a general escape graph. The pop size of a vertex v depends on the pop sizes sampled for vertices
that have an edge pointing to it and the Markov chain begins from the founder vertex and moves outwards.
In the context of the escape graph in Figure 1, forcing the M1 stochastic interval to end before the M12 stochastic
interval begins requires,
µkT (t
(M1)
end )IM1(t
(M1)
end ) < . (3)
The product kT (t) is between 1− 2 in early infection and, generally, can be taken near 1. Then recalling that IM1(t(M1)end )
is sampled from XM1, we always have IM1(t
(M1)
end ) of order L. All this gives the requirement for , which holds generally,
that  > µL.
Choosing an  > 0 means that mutations of variant v′ to v occurring prior to the start of v’s stochastic interval will
be ignored. Such mutations have a probability of order  of occurring with the exact value depending on k, typically
though the probability is slightly less than . All this means that with probability 1− , no such mutations occur and our
assumption of  > 0 does not affect the simulation of the birth-death process. Importantly, our posteriors and p-values are
accurate for the subset of the birth-death process realizations that do not have such early mutations.
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2.3 Computing the Posterior
Let S(t) be the state at time t of the populations tracked by the birth-death process, e.g. for the escape graph of Figure
1, S(t) = (T (t), IF (t), IM1(t), IM12(t)). Let Dˆ(t1, t2) be frequency data for the variants of the escape graph collected at
time points t1, t2. We choose two time points simply for concreteness, any number of data time points are possible. For
example, the CH58 data discussed in the Results section includes three time points, see Table 2. Letting θ represent the
parameters of the birth-death process for which we want to build a posterior, we can simulate the birth-death process and
generate samples for S(t1), S(t2). Let D(S(t1), S(t2)) be the data generated by simulating the birth-death process and then
simulating the task of sampling sequences. By this we mean that first, through simulation, S(t1), S(t2) must be sampled
to establish the exact frequencies of the variants at times t1, t2. Then, since the data produced in [11] comes from sampled
HIV sequences, hypothetical samples must be drawn at time t1 and t2 to form simulated data.
Given a prior for θ, pi(θ), our goal is to compute a posterior of θ conditioned on the data. More precisely, we aim to
compute
P (θ | D(S(t1), S(t2)) = Dˆ(t1, t2)). (4)
However, it is easier to compute a posterior for θ, S(t1), S(t2),
P (θ, S(t1), S(t2) | D(S(t1), S(t2)) = Dˆ(t1, t2)), (5)
and (4) can be obtained from (5) by treating S(t1) and S(t2) as nuisance parameters.
Bayesian posteriors are often computed through Markov chain Monte Carlo (MCMC) methods, see chapter 7 of [40]
for a review of MCMC theory applied to viral data and [41] for a general review. In our context, implementing such an
approach depends on being able to compute the probability,
P (θ, S(t1), S(t2) | D(S(t1), S(t2)) = Dˆ(t1, t2)). (6)
Once (6) can be computed, various MCMC methods allow one to sample from the posterior of θ. Specifically, we implement
a Metropolis-Hastings based MCMC. Such an approach is not affected if instead of computing (6) we compute
P (θ, S(t1), S(t2),D(S(t1), S(t2)) = Dˆ(t1, t2)). (7)
Indeed, (7) is identical to (6) up to a constant factor and such a proportional factor has no affect on a Metropolis-Hastings
MCMC.
(7) can be expressed as a product of simpler conditional probabilities,
P (θ, S(t1), S(t2),D(S(t1), S(t2)) = Dˆ(t1, t2)) (8)
= P (D(S(t1), S(t2)) = Dˆ(t1, t2) | S(t1), S(t2), θ)P (S(t1), S(t2) | θ)pi(θ).
The factor P (D(S(t1), S(t2)) = Dˆ(t1, t2) | S(t1), S(t2), θ) can be interpreted as a sampling probability. That is, conditioned
on knowing S(t1), S(t2) and hence the frequencies of the variants at times t1, t2, what is the probability of drawing the
data. Computation of such probabilities is standard, see for example the methods of [23]. However, P (S(t1), S(t2) | θ), the
probability of a given system state at t1, t2 given a parameter choice, is not standard.
Our approach is to use the Markov chain reduction to replace S(t1), S(t2) by xˆv for all variants v 6= F . Since the
birth-death process under our approximation is completely determined by the pop size samples, the xˆv are interchangeable
with the S(t). To form the posterior, we replace the S(t1), S(t2) values above by the xˆv. Then the factor P (S(t1), S(t2) | θ)
becomes P (xˆv for v 6= F | θ). This second expression is simply the probability that a Markov chain takes on a certain
state. Since we know the distribution of each xˆv, P (xˆv for v 6= F | θ) can be computed in a standard manner.
We use a random walk Metropolis-Hastings algorithm on θ and the xˆv to form the posterior. For instance, to form the
posterior for patient CH58, θ is 6 dimensional and the xˆv, namely xˆM1 and xˆM12, are two dimensional. Our MCMC then
operates on an 8 dimensional state space. To compute a single step of the MCMC takes approximately .2 seconds on an
Intel I7-2600 using our C++ implementation. For all results below we generated 1.5 million steps for the Markov chain
which takes between 2− 3 days. Various improvements in the C++ implementation, most notably multi-threading, should
significantly improve computation times. Mixing times for the MCMC are roughly on the order of 5, 000 steps.
2.4 Hypothesis Testing
Given an escape graph and a choice of parameters for the birth-death process, our goal is to test the null hypothesis that
the data is formed by the model. Here we let θ represent all the parameters of the birth-death process and the underlying
escape graph, as opposed to the previous section where θ represented only the parameters included in the posterior. The
challenge lies in computing a p-value. More precisely, our goal is to compute the p-value of the data, Dˆ(t1, t2), given θ.
Since the data is multidimensional, the notion of a p-value is not a priori well-defined. However, as in the case of posterior
computations, the Markov chain reduction allows for a simplification.
Using the escape graph of Figure 1 as a concrete case, for a given θ there will be a pair of pop sizes xˆM1, xˆM12 for which
P (D(xˆM1, xˆM12) = Dˆ(t1, t2) | θ) is maximized, here we are replacing D(S(t1), S(t2)) by D(xˆM1, xˆM12) since the pop sizes
completely determine the dynamics of the birth-death process. Generically, the maximum need not be unique, however
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this is the case for the models considered in the Results section. (The case of non-unique maximums can be addressed, but
we do not explore that issue in this paper.) Label the xˆM1, xˆM12 that achieve the maximum as x
data
M1 , x
data
M12. Then we can
assess the p-value of Dˆ(t1, t2) by considering where (x
data
M1 , x
data
M12) falls in the two-dimensional density of XM1, XM12. In
other words, we use pop sizes that maximize the likelihood of the data to determine the p-value.
More precisely, let ΦM1 and ΦM12 be the cumulative densities of XM1 and XM12 respectively. Then let ΦM1(x
data
M1 ) =
qM1 and ΦM12(x
data
M12) = qM12. If x
data
M1 was chosen from the density of XM1, qM1 would be uniformly distributed on [0, 1].
The same holds for qM12. Further, note that under the null hypothesis qM1 and qM12 are independent because the sampling
from the the pop size distributions XM1 and XM12 occurs independently even though the distribution XM12 depends on
XM1.
We can then define the p-value by computing the probability with which two independent, uniform random numbers
are more ’extreme’ than qM1, qM12. More precisely, let Ω be the unit square produced by combining all pairs of numbers
both falling in [0, 1]. Let f(x) for x ∈ [0, 1] be the shortest distance from x to either 0 or 1, i.e. f(x) = min(x, 1−x). Then
we define the p-value associated with θ by,
p-value of θ = P (f(u1)f(u2) < f(x
data
M1 )f(x
data
M1 )) (9)
where u1, u2 are uniform samples from [0, 1]. In words, f(x
data
M1 )f(x
data
M1 ) is a measure of how far the pair x
data
M1 , x
data
M1 is
from the boundary of Ω and we set the p-value to be the probability that two uniform samples from [0, 1] are closer to the
boundary under this measure than xdataM1 , x
data
M1 . For example, the pair .5, .5 will have a measure of .5
2 from the boundary
of Ω which is greater than any other point. Hence .5, .5 would have a p-value of 1. In practice, we evaluate (9) through
Monte Carlo methods by sampling 107 pairs of u1, u2 and determining the fraction of times f(u1)f(u2) < f(x
data
M1 )f(x
data
M1 ).
For escape graphs with more variants, the same idea is employed but in higher dimension.
This definition of p-value may seem non-intuitive as we are comparing samples from the pop size distributions rather
than data values. However, we aim to quantify the degree to which the data is unusual for the model. To assess this, we
map the data to the probability space of the model through the Markov chain reduction. Then, since the Markov chain
has a simple probabilistic structure, p-values can be defined and computed more readily.
3 Results
The data we consider is summarized in Figure 2 of [11], although we also exploit linkage information provided by the sequence
data not reflected in the figure. In [11], the time points of the data are measured in days since patient identification. So for
example, day 0 represents the time of initial identification rather than the day of initial infection. To make this distinction
clear, we always use ’day x’ to mean x days since patient identification and ’t = x’ to mean x days since initial infection.
The data we use for CH58 is composed of time points day 9 and day 45 at which 7 and 9 sequences are available as
well as day 0 data in which the founder variant is homogeneous. The stochasticity associated with such small sample sizes
is large and overwhelms the stochasticity of the birth-death process that we aim to highlight. For example, in [23], the
escape rate at epitope ENV EL9 (introduced and discussed below) is estimated as .1 but with a 95% confidence interval of
[.005, .808] (see Figure S3, row ENV 581 in [23]). Since the aim of this paper is to highlight the model, the results presented
for CH58 below assume that the frequency data is generated from 1000 sequences at each timepoint, a modest value for
deep sequencing datasets. Our posteriors are then analogous to the .1 value of [23] with the stochasticity described by the
posterior coming mainly from the birth-death process but also from the sampling of 1000 sequences per timepoint. For
CH40, deep sequencing is available in [29] and our results correspond to the level of sampling given in that dataset.
For both patient CH58 and CH40 we choose L = 2000, making a conservative choice to insure accuracy for the stochastic-
deterministic decomposition. For patient CH40, since the escape graph contains only edges emanating from the founder,
we can choose  = 0 without worry of overlapping stochastic intervals. In this case then, our simulation and the resultant
priors and hypothesis tests apply to all realizations of the birth death process. For patient CH58, we choose  = .06 to
insure a separation between the M1 and M12 stochastic intervals. As a result we ignore roughly 6% of the birth-death
process realizations.
For patients CH58 and CH40 we set k = 2.6 ∗ 10−3 and k = 3 ∗ 10−3, respectively. For both patients we set d = .01,
λ = 108. The parameters were chosen to match the time of peak viral loads suggested by the data as well as to fall within
a biologically reasonable range [17, 37, 38]. Choices for the δ death rates and attack intervals are discussed separately for
each patient.
3.1 Patient CH58:
For patient CH58, we consider data collected in the first three time points : day 0, day 9, and day 45. The patient was
identified in Fiebig stage II and according to viral load data, day 0 corresponds to a time slightly prior to peak viral load
(see Figure S1 in [11]). We make the rough estimate that t = 20 corresponds to day 0. Other choices in the range t ∈ [15, 25]
are reasonable, but the basic results we present do not change.
In [11], two regions on the founder genome experienced rapid, early escape. The first region contains the ENV EL9
epitope (see CH58.e in Figure 2 of [11]) which elicited a ”very early dominant but transient” T cell response. The second
region which we label as ENV 830 corresponding to its location relative to the HXB2 genome (see CH58.g in Figure 2
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of [11]) was not associated with a known epitope or experimentally identified T cell response. Three other regions of early
escapes were found in [11], but the escapes at these regions came slightly after the escapes at ENV EL9 and ENV 830 and
were still in their initial stages at day 45. ICS data showed a strong memory CD8 T cell response to ENV EL9 at day 21,
but a very weak response by day 45, see Figure 7 in [11] and Figure S5B in [23].
Table 2 shows escape percentages at ENV EL9 and ENV 830 for the three timepoints. The first three columns give,
from left to right, the percentage of samples that have mutations in ENV EL9 and the ENV 830 region; ENV EL9 only;
and ENV 830 region only; respectively. The fourth column, corresponds to the percentages found in Figure 2 of [11] and
gives the percentage of mutants in the ENV EL9 region with the status of the ENV 830 region ignored. Table 2 suggests
that the escapes at ENV EL9 and ENV 830 overlap. Our goal in this section is to investigate the escape rates of the sweeps
at these two genome locations in a way that accounts for their interaction.
Table 2. CH58 Data
day ENV EL9 and 830 ENV EL9 only ENV 830 only ENV EL9 ignoring 830
0 0% 0% 0% 0%
9 0% 28% 0% 28%
45 89% 0% 0% 89%
The data presented in the previous two paragraphs suggests an escape graph of the form given in 1 with F , M1, and
M12 playing the role of variants of founder type, variants with escape mutations in ENV EL9 alone, and variants with
mutations in ENV EL9 and the ENV 830 region. We separate the dynamics into three attack intervals, t = 0 to t = 15,
t = 15 to t = 30, and t = 30 to t = 65, through which we form piecewise constant estimates for δF (t), δM1(t) and δM12(t).
The time interval t = 0 to t = 15 is meant to model the period prior to immune system attack. The split of the second and
third attack intervals at t = 30 allows for the change in T cell attack at ENV EL9 implied by the data.
Table 3 gives the δ parameters of the model, 9 in all. However, δM12,1 (the death rate during t ∈ [0, 15] of M12 variants)
is not relevant because there are no M12 variants during that time period. We set δF,1 = .4 following standard estimates
on HIV infected cell lifetimes. The data does not bound the value of δM1,3 from above. Indeed, there are no M1 variants
in the data at day 45 so there can be no upper bound on the death rate of M1 variants during the interval between day 9
and day 45. Consequently, we do not view δM1,3 as adding a full dimension to the posterior. Finally then, the posterior is
6 dimensional corresponding to the parameters : δM1,1, δF,2, δM1,2, δM12,2, δF,3, δM12,3.
Table 3. CH58 Parameters
variant δ during [0, 15] δ during [15, 30] δ during [15, 65]
F δF,1 δF,2 δF,3
M1 δM1,1 δM1,2 δM1,3
M12 δM12,1 δM12,2 δM12,3
In terms of our parameters, we define
escape rate 1 = δF,2 − δM1,2
escape rate 2 = δF,3 − δM12,3
which quantify the rate of escape at the two regions. This matches, in terms of our model, the escape rate definition given
in [22] and used in [11] and [23].
Figures 4A-C give escape rate 1 posteriors with δM1,1 = .4, .6, 10, respectively. For all other parameters our prior was
a uniform distribution on [0, 2]. The value δM1,1 = 10 is not plausible biologically, but is useful in understanding the
relationship between δM1,1 and escape rate 1. As δM1,1 rises, the number of ENV EL9 mutants in existence at t = 15, the
time immune response begins, drops. Biologically, a larger δM1,1 means that the ENV EL9 mutants are less fit. With a
lower number of mutants at t = 15, the escape rate on [15, 30] needs to be higher in order to fit the data, specifically the
day 9 frequencies. Since an ENV EL9 mutant is not expected to be more fit than the founder variant, i.e. δM1,1 > .4,
and since δM1,1 < 10 is reasonable, Figures 4A-C show that the posterior of escape rate 1 falls somewhere in the range of
.35 to .6. Figure 4D gives the posterior of escape rate 1 when using a uniform prior of [.4, .7] on δM1,1 and [.4, 2] on all
other parameters. This prior assumes a fitness cost for all mutants over the founder variant. As can be seen, Figure 4D is
roughly a combination of Figures 4A and 4B and gives a range for escape rate 1 of .4 to .55.
Figure 5 gives the posterior for escape rate 2 which falls roughly in the range [.1, .3]. The posterior was generated with
a prior on δM1,1 and δM1,2 that is uniform on [.4, .7] and [.4, 1], respectively. All other parameters had a uniform prior on
[0, 2]. Altering δM1,2 has an analogous effect on escape rate 2 as altering δM1,1 has on escape rate 1. A relatively large
value for δM1,2 means that ENV EL9 mutants will die off more quickly, allowing ENV EL9 + ENV 830 mutants to rise
more quickly, and in turn reducing escape rate 2. Figure 6 gives a heat map for posterior values of the variables δM1,2 and
escape rate 2 showing this inverse relationship.
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Figure 4. Escape Rate 1 Posteriors. Escape rate 1 measures the rate of escape at epitope ENV EL9. Posteriors shown
in A-C were generated with a uniform prior on [0, 2] for all parameters in Table 3, except that δF,1 = .4 and (A) δM1,1 = .4
(B) δM1,1 = .6 (C) δM1,1 = 10. The posterior in D was generated using a uniform prior of [.4, 2] for all parameters, except
δF,1 = .4 and δM1,1 was assigned a uniform prior on [.4, .7]. All posteriors were generated by running an MCMC for 1.5 ∗ 106
steps.
Table 4 gives a set of parameter values which we label as parameter set a. We also consider parameter set b, which we
take identical to set a except with δF,2 = 1.05 rather than δF,2 = 1.1. Escape rate 1 for parameter sets a and b is .5 and
.45 respectively, both parameters sets have an escape rate 2 of .2. Table 5 gives the pop sizes and p-values for these two
parameter sets. The pop sizes shown in the table are those associated with the p-value, i.e. the pop sizes that maximize
the likelihood of the data. Connecting to Figure 4B (since δM1,1 = .6 in both sets) and Figure 5, parameter set a reflects
escape rates in the middle of the posterior while parameter set b has an escape rate 1 on the left edge of the posterior.
Correspondingly, the overall p-value drops from .42 for set a to .02 for set b.
Table 4. Parameter Set a
variant δ during [0, 15] δ during [15, 30] δ during [15, 65]
F δF,1 = .4 δF,2 = 1.1 δF,3 = .9
M1 δM1,1 = .6 δM1,2 = .6 δM1,3 = 1
M12 − δM12,2 = .4 δM12,3 = .7
Intuitively, when the birth-death process is defined by parameter set b, a rare event has to occur to generate the CH58
data. On the other hand, the CH58 data is ’typical’ for the birth-death process defined by parameter set a. The nature
of such rare or typical events are understood through the pop size distribution used to define the p-values. Focusing on
parameter set a for a moment, Figure 7A shows the M1 pop size distribution, XM1. More explicitly, the stochastic interval
of M1 variants is [6.9, 14.2] and so the pop size distribution is precisely the distribution of IM1(14.2). Figure 7B shows the
likelihood of the data given different values for the M1 pop size, xˆM1. The maximum likelihood is achieved at xˆM1 = 1930.
Returning to Figure 7A, a pop size of 1930 has a p-value of .7 as noted in Table 5. Figures 7C,D shows the same graphs but
for the M12 pop size with the M1 pop size fixed at 1930. Figure 8 shows the same graphs as Figure 7 but for parameter
set b. Notice from Figure 8B that in this case the maximum likelihood of the M1 pop size occurs at 5330 which is far to
the right on the distribution of M1 pop size as shown in Figure 8A. This results in the p-value of .006 noted in Table 5.
Combining the p-values from the M1 and M12 pop sizes gives the overall p-value.
Table 5. Pop Sizes and p-Values for Parameter Sets a and b
xˆM1 xˆM12 xˆM1 p-value xˆM12 p-value overall p-value
a 1930 4570 .7 .12 .42
b 5330 4150 .006 .12 .02
Figures 9A-C show the dynamics produced by parameter set a with pop size values as given in Table 5. Figures 9A,B
give population sizes in units of 109 infected cells while Figure 9C gives population frequencies. There is about a three
log difference shown in graph Figure 9A,B between the time of peak viral load at t = 33 and t = 65, this is similar to the
change in viral load seen in patient CH58. The variant percentages shown in Figure 9C at days 9 and 45 are within 1% of
those given in Table 2.
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Figure 5. Escape Rate 2 Posterior. Escape rate 2 measures the rate of escape in the region including ENV 830. The
posterior was generated with a uniform prior on [0, 2] for all parameters in Table 3 except δF,1 = .4 and δM1,1, δM1,2 were
assigned uniform priors on [.4, .7] and [.4, 1], respectively. See Figure 4 for all other parameter values. The posterior was
generated by running an MCMC for 1.5 ∗ 106 steps.
Figure 9C shows that the escape dynamics associated with parameter set a can be decomposed into two sweeps, one by
M1, i.e. ENV EL9 mutants, and one by M12, i.e. ENV EL9 + ENV 830 mutants. As can be seen from the graph the ENV
EL9 + ENV 830 mutant sweep does not permit the ENV EL9 sweep to finish. We can give an ad-hoc biological explanation
for the values of parameter set a. The ENV EL9 mutation comes at an absolute fitness cost of .2, i.e. the difference between
δM1,1 and δF,1. From t = 15 to t = 30, CTL attack at ENV EL9 is enough to make up for this fitness cost and ENV
EL9 mutants begin to push out founder variants. From t = 30 to t = 65 the force of CTL attack at ENV EL9 drops, as
suggested by the CTL data and attack at other epitopes begins. Since the CTL attack is no longer focused on ENV EL9,
the fitness cost of ENV EL9 mutants causes them to be selected against with respect to founder variants, However, during
this period ENV EL9 + ENV 830 mutants rise up. ENV 830 region mutations are possibly compensatory mutation, and so
ENV EL9 + ENV 830 mutants are not exposed to the remaining CTL attack at ENV EL9 and do not pay the fitness price
of ENV EL9 mutants. As a result, ENV EL9 + ENV 830 mutants begin to sweep through the population. We emphasize
that this explanation is simply meant to give some intuition to the parameter values and the resulting dynamics, we do
not suggest that our results provide conclusive evidence for this biological interpretation.
Finally, we note that when the birth-death process is run under parameter set a without conditioning on the data the
dynamics will rarely fit the data. Figure 10A shows the distribution of the frequency of founder variants at day 9. CH58
data has the founder variant frequency of 72% at day 9. This value indeed has a significant density in the distribution
shown, hence the high p-value of parameter set a, but the birth-death process will typically not generate a frequency of 72%.
Parameter set b produces a similar density, seen in Figure 10B, but with .72 located in the tail of the density corresponding
to the low p-value of parameter set b.
3.2 Patient CH40:
For patient CH40, early escapes were identified at two epitopes : NEF SR9 (CH40.t in Figure 2 in [11]) and GAG CR9
(CH40.b in [11]). The first three timepoints sampled are day 0, 16, 45. NEF SR9 mutants are present in the data by day
16 while GAG CR9 mutants are not present until day 45. With this in mind, we restrict our attention to NEF SR9 and the
days 0 and 16 allowing us to exploit the deep sequencing data for NEF SR9 described in [29]. At day 0, the data in [29] is
essentially homogeneous for NEF SR9. Table 6 gives the different NEF SR9 mutants found at day 16 and is produced from
data in Figure 5 of [29]. More precisely, we considered all variants in the figure with frequency greater than 1% at day 16.
10
0.5 0.6 0.7 0.8
0.
15
0.
20
0.
25
δM1,2
Es
ca
pe
 R
at
e 
2
Figure 6. Posterior of escape rate 2 and δM1,2. See figure 5 for priors and 4 for all other parameter values.
For those variants, frequencies were rounded to the nearest tenth and rescaled (by a factor of 1.033) so that frequencies
summed to 100%. Each NEF SR9 mutant is associated with a one letter label as specified in the table.
Table 6. CH40 Data at day 16
label a.a. sequence frequency at day 16
F SLAFRHVAR 50%
Q ——–Q 4.7%
H —-H—- 24.9%
N N——– 1.9%
R R——– 3.8%
M ——M– 5.6%
E ——E– 2.0%
C —-C—- 5.7%
I I——– 1.4%
The striking feature of Table 6 is the high frequency of H variants with respect to the other mutant variants. This
deviation may be explained by differences in fitness, mutation rate, pMHC binding, or CTL recognition. But before turning
to such explanations, it is valuable to consider whether the deviation could be caused by stochastic effects alone.
To address this issue, we consider different null hypotheses assuming all mutant variants to be identical, meaning under
our model that their birth, death, and mutation rates are equal. Figure 2 shows the escape graph we assume. We separate
the dynamics into two attack intervals, t = 0 to t = tA, t = tA to t = 36 (day 16 corresponds to t = 36). tA is the time at
which we assume CTL attack on NEF SR9 to begin and we consider tA between t = 12 and t = 19. Table 7 describes the
death rates assumed by the null hypotheses. All variants, including the founder, have δ = .4 for t ∈ [0, tA]. For t ∈ [tA, 36],
all mutants share the same death rate denoted δM while the founder death rate is denoted δF . In total we have three
parameters that identify different null hypotheses, tA, δF , δM . But all null hypotheses parametrized in this manner assume
identical mutants.
Figure 11 provides the p-value for different values of tA with δM = .4, δF = .56. The results are similar in trend with
respect to tA for all δM , δF , but with lower p-values. The maximum p value of .011 occurs at tA = 14. The p-value is
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Figure 7. Parameter Set a Pop Size Distribution and Likelihood. A-D are generated using parameter set a with
k = 2.6 ∗ 10−3 , d = .01, λ = 108. (A) Distribution of XM1, the number of M1 variants at the end of the M1 stochastic
interval. (B) The likelihood of the data given different values for xˆM1. xˆM12 is chosen to maximize the likelihood given a
value of xˆM1. (C) Distribution of XM12, the number of M12 variants at the end of the M12 stochastic interval. (D) The
likelihood of the data given different values for xˆM12 with xˆM1 = 1930.
2000 4000 6000 8000 10000
0.
00
0.
04
0.
08
Number of M1 Variants
D
en
si
ty
A
2000 4000 6000 8000
−
5
−
3
−
1
Number of M1 Variants
Li
ke
lih
oo
d
B
2000 4000 6000 8000 10000
0.
00
0.
02
0.
04
Number of M12 Variants
D
en
si
ty
C
3000 3500 4000 4500 5000 5500 6000
−
5
−
3
−
1
Number of M12 Variants
Li
ke
lih
oo
d
D
Figure 8. Parameter Set b Pop Size Distribution and Likelihood. A-D are generated using parameter set b with
k = 2.6 ∗ 10−3 , d = .01, λ = 108. (A) Distribution of XM1, the number of M1 variants at the end of the M1 stochastic
interval. (B) The likelihood of the data given different values for xˆM1. xˆM12 is chosen to maximize the likelihood given a
value of xˆM1. (C) Distribution of XM12, the number of M12 variants at the end of the M12 stochastic interval. (D) The
likelihood of the data given different values for xˆM12 with xˆM1 = 5330.
small, although not exceptionally extreme. Nevertheless, one might reject this null hypothesis, especially since values of
tA 6= 14 generate p-values much lower than .01. Before continuing, we point out that the low p-value is a result of the many
variants revealed by deep sequencing. For example, if all the mutants are grouped into a single mutant with a mutation
rate of 8µ and the parameters set at tA = 15, δM = .4 then Figure 12 shows the p-value as we consider hypotheses with
varying δF . At δF = .62 a p-value of .81 is obtained.
Having rejected the null hypothesis that all mutant variants are identical, a natural second hypothesis would be that
all 7 mutant variants other than H are identical. We can test this hypothesis using escape graph 2 and the parameters of
Table 7, except that we add a parameter δH as the death rate of H mutants during [tA, 36]. Figure 13A shows p-values
under δH = .4, δM = .52, δF = .67 for hypotheses with different tA. The maximum p-value is .11 achieved as t = 12.5.
Figure 13B is generated with identical parameters, except that δF = .7. The maximum p-value is .05 which is achieved
at the relatively late time of tA = 17. Figures 13A,B reflect a general trend, as the death rates on the founder and non-H
mutant variants are raised, the attack time must be increased to provide significant p-values. Roughly, raising death rates
provides a greater advantage to H variants that can be offset by shortening the duration of attack.
While the preceding discussion provides some statistical perspective on early escape in patient CH40, we hasten to add
that day 45 data may well change the picture. Indeed, a failure to reject the null hypothesis is not proof of its truth.
At day 45, Q variants come to dominate the population while H variants drop to low levels (see [29] for more details).
One explanation for these dynamics is that Q variants are more fit than H variants but are exposed to stronger selection
by CTLs targeting NEF SR9, similar in some ways to the dynamics seen in patient CH58. Given these observations, it
may be appropriate to remove the assumption in our null hypotheses that all mutant variants are equally fit prior to CTL
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Figure 9. Dynamics under Parameter Set a. Dynamics shown are formed using parameter set a with xˆM1 and xˆM12
given in Table 5. (A),(B) population sizes of the three variants in units of 109 infected cells. (C) population frequencies of
the three variants.
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Figure 10. Founder Variant Frequency Distribution at day 9. (A) parameter set a (B) parameter set b.
response. However, one must also consider the CTL response at GAG and the lack of data linking GAG to NEF for CH40
complicates the analysis.
4 Discussion
HIV escape from CTL attack during acute infection is a remarkable example of evolution. In the time span of approximately
2 months the infecting HIV population is targeted by CTL response at 1 − 3 epitopes, experiences massive changes
in population size, and escapes CTL selective pressure at the targeted epitopes through multiple mutation pathways
[5, 10,11,29]. The resulting HIV selective sweeps are complex in two ways.
First, HIV selective sweeps are high-dimensional. As the data collected in [11] suggests, many variants are involved in an
HIV selective sweep and each such variant represents a potential dimension in a model system. Second, HIV selective sweeps
are likely stochastic. Escape variants must initially have small population sizes which are affected by the stochasticity of
life cycle and mutation events. This early stochasticity of escape variants can substantially affect HIV selective sweeps as
demonstrated by our model and results. Indeed, Figure 10 shows that significant variation in founder frequency soon after
peak viral load can be produced by the early stochasticity of escape variant dynamics.
Corresponding to the complexity of HIV selective sweeps, recent studies have provided high-dimensional datasets that
track multiple HIV variants through multiple time points, e.g. [10, 11,29]. In this work we have presented a model of HIV
dynamics during acute infection that can incorporate multiple escape variants, through the escape graph, in a stochastic
setting, through the birth-death process. Under this model, we have developed inference methods that allow us to exploit
high-dimensional datasets.
The results presented for patient CH58 highlight the need to consider multiple variants at once. The early escape
dynamics for patient CH58 involved escape in two regions of the genome. The two escapes occurred simultaneously and,
according to our inference results, affected each other. To infer such dynamics, high dimensional models that include
multiple variants must be considered.
The results presented for patient CH40 highlight the utility of null models in analyzing HIV escape. We know that
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Table 7. CH40 Parameters
variant δ during [0, tA] δ during [tA, 36]
F .4 δF
mutants .4 δM
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Figure 11. Null Hypotheses assuming all mutant variants are identical. tA models the time of immune system
response in days since infection.
HIV escape occurs through multiple mutation pathways. Different mutations will likely have different fitness costs and
differing levels of escape from MHC presentation and CTL killing. Multiple variants requiring multiple parameters leads
to significant problems related to inference and over-fitting. Null models can serve a purpose in this context by shifting the
question from identification of numerous parameters to identification of variants that are in some way unique and should
potentially be the object of further analysis.
While we have presented a basic framework for computational inference of HIV selective sweeps, there are features of
our approach that require more work. For example, we have not considered the issue of parameter identifiability, see [42] for
a review. As the number of parameters grows, understanding which combination of parameters can be inferred through a
posterior becomes essential. The computations we have presented occurred on state spaces of modest dimension. Limiting
our analysis to the initial CTL response allowed for this, but future work should extend to the first wave of CTL responses
that target 1−3 epitopes. While our methods should apply to this greater context, understanding how to construct escape
graphs and birth-death processes that can extract biologically useful information in this more computationally challenging
setting requires further work.
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Figure 12. Null Hypotheses assuming a single mutant variant. tA models the time of immune system response in
days since infection.
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Figure 13. Null Hypotheses assuming all mutant variants are identical except for variant H. tA models the
time of immune system response in days since infection.
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